Significance of the association between heparin-binding epidermal growth factor-like growth factor and CD9 in human gastric cancer

International Journal of Cancer

Volumn 98, Issue 4, 2002, Pages 505-513

  Murayama, Yoko ^a   Miyagawa, Jun Ichiro ^a   Shinomura, Yasuhisa ^a   Kanayama, Shuji ^a   Isozaki, Koji ^a   Yamamori, Katsumi ^a   Mizuno, Hitoshi ^a   Ishiguro, Shingo ^b   Kiyohara, Tatsuya ^a   Miyazaki, Yoshiji ^a   Taniguchi, Naoyuki ^a   Higashiyama, Shigeki ^c   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

CD9; Gastric cancer; HB EGF; Juxtacrine manner

Indexed keywords

CD9 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; MESSENGER RNA;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CANCER GRADING; CARCINOGENESIS; CELL MEMBRANE; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; STOMACH CANCER; TISSUE LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; BLOTTING, WESTERN; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 0036533673     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10198     Document Type: Article

References (54)

1. Autocrine growth factors and cancer
2. Peptide growth factors are multifunctional
3. Growth factors and oncogenes in human gastrointestinal carcinomas
4. Expression of amphiregulin, a novel gene of the epidermal growth factor family, in human gastric carcinomas
5. Co-expression of heparin-binding EGF-like growth factor and related peptides in human gastric carcinoma
6. Transforming growth factor α expression in normal gastric mucosa, intestinal methaplasia, dysplasia and gastric carcinoma: An immunohistochemical study
7. Expression of heregulin α, erbB2, and erbB3 and their influences on proliferation of gastric epithelial cells
8. Increased epidermal growth factor receptors in gastric carcinomas
9. Expression of epidermal growth factor receptor in human gastric and colonic carcinomas
10. Specificity within the EGF family/ErbB receptor family signaling network
11. Isolation and characterization of a macrophage-derived heparin binding growth factor
12. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF
13. Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: Dependence on interactions with cell surface heparan sulfate
14. Heparin-binding EGF-like growth factor is a potent mitogen for rat hepatocytes
15. Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes
16. Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury
17. Heparin-binding EGF-like growth factor is an autocrine growth factor for rat gastric epithelial cells
18. Localization of heparin-binding epidermal growth factor-like growth factor in human gastric mucosa
19. Induction and expression of heparin-binding EGF-like growth factor in human pancreatic cancer
20. Expression of heparin-binding epidermal growth factor in human hepatocellular carcinoma
21. Bimodal expression of heparin-binding EGF-like growth factor in colonic neoplasms
22. Structure of heparin-binding EGF-like growth factor: Multiple forms, primary structure, and glycosylation of the mature protein
23. The membrane protein CD9/DRAP27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor (HB-EGF)
24. Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: Conversion from juxtacrine to paracrine growth factor activity
25. Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology
26. Functional analysis of four tetraspans, CD9, CD53, CD81, and CD82, suggests a common role in costimulation, cell adhesion, and migration: Only CD9 upregulates HB- EGF activity
27. The teteraspanin superfamily: Molecular facilitators
28. The activation of human platelets mediated by anti-human platelet p24/CD9 monoclonal antibodies
29. Anti-CD9 monoclonal antibodies induce homotypic adhesion of pre-B cell lines by a novel mechanism
30. Characterization and distribution of a 24,000- molecular weight antigen defined by a monoclonal antibody (DU-ALL-1) elicited to common acute lymphoblastic leukemia (cALL) cells
31. Molecular cloning of the CD9 antigen. A new family of cell surface proteins
32. CD9, a major platelet cell surface glycoprotein, is a ROCK antigen and is expressed in the nervous system
33. The two histological main types of gastric carcinoma
34. The general rules for the gastric cancer study in surgery and pathology
35. Single-step method of RNA isolation by acid guanidine thiocyanate-phenol-chloroform extraction
36. An antibody that inhibits the binding of diphtheria toxin to cells revealed the association of a 27-kDa membrane protein with the diphtheria toxin receptor
37. DNA sequencing with chain terminating inhibitors
38. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells
39. Heparin-binding EGF-like growth factor: Characterization of rat and mouse cDNA clones, protein domain conservation across species, and transcript expression in tissues
40. Localization of mRNA for c-kit receptor and its ligand in the brain of adult rats: An analysis using in situ hybridization histochemistry
41. Expression of heparin binding epidermal growth factor-like growth factor in hepatocellular carcinoma: An immunohistochemical study
42. Motility related protein 1 (MRP-1/CD9) expression: Inverse correlation with metastases in breast cancer
43. Immunohistochemically detected expression of motility-related protein-1 (MRP-1/CD9) in lung adenocarcinoma and its relation to prognosis
44. Transmembrane 4 superfamily as a prognostic factor in pancreatic cancer
45. Evidence that the signal-initiating membrane protein CD9 is associated with small GTP-binding proteins
46. Anti-CD9 monoclonal antibody elicits staurosporine inhibitable phosphatidylinositol 4,5-bisphosphate hydrolysis, phophatidylinositol 3,4-bisphosphate synthesis, and protein-tyrosine phosphorylation in human platelets
47. Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA
48. Motility related protein-1 (MRP-1/CD9) reduction as a factor of poor prognosis in brest cancer
49. Reduced motility related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer
50. Expression of the neuroglandular antigen and analogues in melanoma. CD9 expression appears inversely related to metastatic potential of melanoma
51. Motility related protein (MRP1/CD9) expression in colon cancer
52. Possible role of coexpression of CD9 with membrane-anchored heparin-binding EGF-like growth factor and amphiregulin incultures human keratinocyte growth
53. High expression of heparin-binding EGF-like growth factor in rat hepatocarcinogenesis
54. The membrane-bound form of heparin-binding epidermal growth factor-like growth factor promotes survival of cultured renal epithelial cells